Cipla to Launch Generic Palonosetron in U.S.

[mnholdem]

Injected drug, not the inhaled API in MannKind’s pipeline.

blog.cipla.com/in-the-news/cipla-launches-authorized-generic-aloxi-palonosetron-hcl-injection-0-25-mg5-ml/

[mnholdem]

It’s interesting that Cipla’s business plan involves many generics. I’ve often wondered whether Technosphere delivery of multiple generic drugs would have the benefits of faster regulatory approval timelines and trial costs when developing drug-device candidates where both the API and device already have FDA approval.

[lennymnkd]

Mn / is that the case for TEVA sounds  like it might be .